Gliomagenesis: genetic alterations and mouse models
- 1 February 2001
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Genetics
- Vol. 2 (2), 120-129
- https://doi.org/10.1038/35052535
Abstract
Glioblastoma multiforme is the most malignant of the primary brain tumours and is almost always fatal. The treatment strategies for this disease have not changed appreciably for many years and most are based on a limited understanding of the biology of the disease. However, in the past decade, characteristic genetic alterations have been identified in gliomas that might underlie the initiation or progression of the disease. Recent modelling experiments in mice are helping to delineate the molecular aetiology of this disease and are providing systems to identify and test novel and rational therapeutic strategies.Keywords
This publication has 58 references indexed in Scilit:
- Astrocytes Give Rise to Oligodendrogliomas and Astrocytomas after Gene Transfer of Polyoma Virus Middle T Antigen in VivoThe American Journal of Pathology, 2000
- Mammalian Neural Stem CellsScience, 2000
- Development of a flexible and specific gene delivery system for production of murine tumor modelsOncogene, 1999
- Reversible Activation of c-Myc in SkinMolecular Cell, 1999
- Development and malignant progression of astrocytomas in GFAP-v-src transgenic miceOncogene, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Retrodifferentiation and Cell DeathCritical Reviews™ in Oncogenesis, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Effects of an Rb mutation in the mouseNature, 1992
- Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomasJournal of Neurosurgery, 1992